79 results
Page 3 of 4
8-K
EX-99.1
5mvmjxsyg
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
dcu0 7smv
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-10.2
kpxn3hikpg e1j8e
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
ouxua1vmuoqwuic1na0s
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.13
z574r7
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.19
429comum nrej0
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.16
rtcvnv 3n35bm1rj
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
vkvf01
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.13
hbrpvof vdfvt
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.17
7h5g585
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
9lf r6le8t4
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
mt1fyeb9 pqjo
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
mrsgyrje02ijhry317
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
ckwr21ltsizb
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
fc9j6th7j32 g7xb
15 Mar 21
Business combination disclosure
8:20am
8-K
hcszly11pog2e3a9l
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
qu22 pxpauzf
5 Mar 21
Annual report
8:13am